tirzepatide injection brand name Zepbound® Lilly launches lower-price weight-loss drug

Your risk for getting low blood sugar may be higher if you use MOUNJARO with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin

Weight loss above 15%, seen with Novos Wegovy (at 68 weeks), is the minimum bar

There are ongoing studies including a large phase 3 trial underway to determine if semaglutide will meet any of these clinical endpoints for FDA approval

Latorre R, Ramirez-Garcia PD, Hegron A, Grace JL, Retamal JS, Shenoy P, et al

(2019) 60:E15

It also helps you tune in to fullness cues, which GLP-1 will amplify, you may feel full on much less food, which is an adjustment mentally